Boston Family Office’s Health Catalyst HCAT Stock Holding History

Boston Family Office’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,274	Closed	-$295K	–	277
2022 Q1	$295K	Buy	11,274 +250	+2%	+$7.09K	0.02%	245
2021 Q4	$437K	Buy	11,024 +4,633	+72%	+$211K	0.03%	222
2021 Q3	$320K	Buy	6,391 +1,289	+25%	+$70.3K	0.02%	238
2021 Q2	$283K	Buy	+5,102	New	+$272K	0.02%	245

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Boston Family Office's HCAT Position: Q2 2022 in Review

Boston Family Office sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 11,274 shares — an estimated $295K sold.

Boston Family Office first reported a position in HCAT in Q2 2021 and held it in 4 quarters. The position peaked at $437K in Q4 2021. 180 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

Boston Family Office reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
Boston Family Office sold 11,274 Health Catalyst shares in Q2 2022, an estimated $295K.
Boston Family Office first reported a position in Health Catalyst in Q2 2021 and held it in 4 quarters.
Boston Family Office's Health Catalyst position peaked at $437K in Q4 2021.
180 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Boston Family Office's 13F filing for Q2 2022, filed 11 Aug 2022.